Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.

Author: GollnickHarald P, QuistSven R

Paper Details 
Original Abstract of the Article :
actinic keratosis is a premalignant disease with a high incidence and is a strong predictor for the development of squamous cell carcinoma. Various treatment options have been established over recent years, including topical treatment with imiquimod, 5-fluorouracil, diclofenac or photodynamic therap...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1517/14656566.2011.549128

データ提供:米国国立医学図書館(NLM)

Treating Actinic Keratoses: A Journey Through Topical Therapies

Actinic keratosis is a common precancerous skin condition that can develop into squamous cell carcinoma. A variety of treatment options exist, ranging from topical therapies like imiquimod, 5-fluorouracil, and diclofenac to procedures like cryotherapy and surgery. This research, published in Journal of Cutaneous Medicine and Surgery, focuses on the topical treatment of actinic keratoses with imiquimod 3.75% cream (Zyclara). The authors provide a comprehensive overview of the different treatments available and the benefits of using imiquimod cream.

Mapping the Landscape of Actinic Keratosis Treatment: Finding the Right Path

This research provides a valuable overview of the treatment options for actinic keratosis, highlighting the potential benefits of topical therapies. The authors provide a comprehensive analysis of the different approaches, emphasizing the need for a personalized treatment plan based on the individual needs of the patient.

A Guide to the Oasis: Protecting Your Skin from Actinic Keratoses

This research underscores the importance of early detection and treatment of actinic keratoses to reduce the risk of developing squamous cell carcinoma. Patients with actinic keratoses should consult with a dermatologist to determine the best treatment option for them. This research offers valuable insights into the different options available, empowering patients to make informed decisions about their care.

Dr. Camel's Conclusion

Like a camel navigating the desert, patients with actinic keratoses need to be aware of their surroundings and seek guidance to navigate the complexities of treatment. This research provides a map of the different options available, empowering patients to make informed decisions about their skin health.
Date :
  1. Date Completed 2011-04-20
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

21254950

DOI: Digital Object Identifier

10.1517/14656566.2011.549128

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.